Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Nov 28:12:29.
doi: 10.1186/1471-2253-12-29.

ASAP ECMO: Antibiotic, Sedative and Analgesic Pharmacokinetics during Extracorporeal Membrane Oxygenation: a multi-centre study to optimise drug therapy during ECMO

Kiran Shekar  1 , Jason A Roberts, Susan Welch, Hergen Buscher, Sam Rudham, Fay Burrows, Sussan Ghassabian, Steven C Wallis, Bianca Levkovich, Vin Pellegrino, Shay McGuinness, Rachael Parke, Eileen Gilder, Adrian G Barnett, James Walsham, Daniel V Mullany, Yoke L Fung, Maree T Smith, John F Fraser
Affiliations

ASAP ECMO: Antibiotic, Sedative and Analgesic Pharmacokinetics during Extracorporeal Membrane Oxygenation: a multi-centre study to optimise drug therapy during ECMO

Kiran Shekar et al. BMC Anesthesiol. .

Abstract

Background: Given the expanding scope of extracorporeal membrane oxygenation (ECMO) and its variable impact on drug pharmacokinetics as observed in neonatal studies, it is imperative that the effects of the device on the drugs commonly prescribed in the intensive care unit (ICU) are further investigated. Currently, there are no data to confirm the appropriateness of standard drug dosing in adult patients on ECMO. Ineffective drug regimens in these critically ill patients can seriously worsen patient outcomes. This study was designed to describe the pharmacokinetics of the commonly used antibiotic, analgesic and sedative drugs in adult patients receiving ECMO.

Methods/design: This is a multi-centre, open-label, descriptive pharmacokinetic (PK) study. Eligible patients will be adults treated with ECMO for severe cardiac and/or respiratory failure at five Intensive Care Units in Australia and New Zealand. Patients will receive the study drugs as part of their routine management. Blood samples will be taken from indwelling catheters to investigate plasma concentrations of several antibiotics (ceftriaxone, meropenem, vancomycin, ciprofloxacin, gentamicin, piperacillin-tazobactum, ticarcillin-clavulunate, linezolid, fluconazole, voriconazole, caspofungin, oseltamivir), sedatives and analgesics (midazolam, morphine, fentanyl, propofol, dexmedetomidine, thiopentone). The PK of each drug will be characterised to determine the variability of PK in these patients and to develop dosing guidelines for prescription during ECMO.

Discussion: The evidence-based dosing algorithms generated from this analysis can be evaluated in later clinical studies. This knowledge is vitally important for optimising pharmacotherapy in these most severely ill patients to maximise the opportunity for therapeutic success and minimise the risk of therapeutic failure.

Trial registration: ACTRN12612000559819.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Sampling schedule for antibiotic drugs.
Figure 2
Figure 2
Sampling schedule for sedative and analgesic drugs. BIS- bispectral index, RASS- Richmond Agitation Sedation Scale.
Figure 3
Figure 3
Demographic and clinical data collection form.
See this image and copyright information in PMC

References

    1. Fraser JF, Shekar K, Diab S, Foley SR, McDonald CI, Passmore M, Simonova G, Roberts JA, Platts DG, Mullany DV, Fung YL. ECMO - the clinician's view. ISBT Science Series. 2012;7:82–88. doi: 10.1111/j.1751-2824.2012.01560.x. - DOI
    1. Beckmann A, Benk C, Beyersdorf F, Haimerl G, Merkle F, Mestres C, Pepper J, Wahba A. Position article for the use of extracorporeal life support in adult patients. Eur J Cardiothorac Surg. 2011;40(3):676–680. - PubMed
    1. MacLaren G, Combes A, Bartlett RH. Contemporary extracorporeal membrane oxygenation for adult respiratory failure: life support in the new era. Intensive Care Med. 2012;38(2):210–220. doi: 10.1007/s00134-011-2439-2. - DOI - PubMed
    1. ECLS Registry report. Extracorporeal Life Support Organisation. Ann Arbor( MI); 2011.
    1. Davies A, Jones D, Bailey M, Beca J, Bellomo R, Blackwell N, Forrest P, Gattas D, Granger E, Herkes R. et al.Extracorporeal membrane oxygenation for 2009 influenza a(H1N1) acute respiratory distress syndrome. JAMA. 2009;302(17):1888–1895. - PubMed